236 related articles for article (PubMed ID: 31088846)
1. Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically.
Chafe SC; McDonald PC; Saberi S; Nemirovsky O; Venkateswaran G; Burugu S; Gao D; Delaidelli A; Kyle AH; Baker JHE; Gillespie JA; Bashashati A; Minchinton AI; Zhou Y; Shah SP; Dedhar S
Cancer Immunol Res; 2019 Jul; 7(7):1064-1078. PubMed ID: 31088846
[TBL] [Abstract][Full Text] [Related]
2. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
[TBL] [Abstract][Full Text] [Related]
4. Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells.
Güttler A; Theuerkorn K; Riemann A; Wichmann H; Kessler J; Thews O; Bache M; Vordermark D
Oncol Rep; 2019 Apr; 41(4):2585-2594. PubMed ID: 30720123
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis.
Andreucci E; Peppicelli S; Carta F; Brisotto G; Biscontin E; Ruzzolini J; Bianchini F; Biagioni A; Supuran CT; Calorini L
J Mol Med (Berl); 2017 Dec; 95(12):1341-1353. PubMed ID: 28929255
[TBL] [Abstract][Full Text] [Related]
6. The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy.
van Kuijk SJ; Gieling RG; Niemans R; Lieuwes NG; Biemans R; Telfer BA; Haenen GR; Yaromina A; Lambin P; Dubois LJ; Williams KJ
PLoS One; 2016; 11(8):e0161040. PubMed ID: 27513947
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
[TBL] [Abstract][Full Text] [Related]
8. Sulfamate inhibitor S4 influences carbonic anhydrase IX ectodomain shedding in colorectal carcinoma cells.
Hektoen HH; Ree AH; Redalen KR; Flatmark K
J Enzyme Inhib Med Chem; 2016 Oct; 31(5):779-86. PubMed ID: 26244271
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion.
Sarnella A; Ferrara Y; Auletta L; Albanese S; Cerchia L; Alterio V; De Simone G; Supuran CT; Zannetti A
J Exp Clin Cancer Res; 2022 Apr; 41(1):122. PubMed ID: 35365193
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
[TBL] [Abstract][Full Text] [Related]
11. Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells.
Parks SK; Cormerais Y; Durivault J; Pouyssegur J
Oncotarget; 2017 Feb; 8(6):10225-10237. PubMed ID: 28055960
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma.
Todenhöfer T; Gibb EA; Seiler R; Kamyabi A; Hennenlotter J; McDonald P; Moskalev I; Stewart C; Gao J; Fazli L; Dedhar S; Stenzl A; Oo HZ; Black PC
Urol Oncol; 2021 Aug; 39(8):498.e1-498.e11. PubMed ID: 34083096
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH.
Chiche J; Ilc K; Laferrière J; Trottier E; Dayan F; Mazure NM; Brahimi-Horn MC; Pouysségur J
Cancer Res; 2009 Jan; 69(1):358-68. PubMed ID: 19118021
[TBL] [Abstract][Full Text] [Related]
14. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.
Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM
Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075
[TBL] [Abstract][Full Text] [Related]
15. Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer.
Bryant JL; Gieling RG; Meredith SL; Allen TJ; Walker L; Telfer BA; Supuran CT; Williams KJ; White A
Int J Cancer; 2018 Jan; 142(1):191-201. PubMed ID: 28905987
[TBL] [Abstract][Full Text] [Related]
16. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
Mahoney KM; Freeman GJ; McDermott DF
Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
[TBL] [Abstract][Full Text] [Related]
17. Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy.
Queirolo P; Boutros A; Tanda E; Spagnolo F; Quaglino P
Semin Cancer Biol; 2019 Dec; 59():290-297. PubMed ID: 31430555
[TBL] [Abstract][Full Text] [Related]
18. Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia.
Pucciarelli D; Lengger N; Takacova M; Csaderova L; Bartosova M; Breiteneder H; Pastorekova S; Hafner C
Int J Oncol; 2015 Jul; 47(1):81-90. PubMed ID: 25997619
[TBL] [Abstract][Full Text] [Related]
19. Carbonic Anhydrase IX Suppression Shifts Partial Response to Checkpoint Inhibitors into Complete Tumor Eradication: Model-Based Investigation.
Grajek J; Poleszczuk J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373220
[TBL] [Abstract][Full Text] [Related]
20. Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts.
Gieling RG; Babur M; Mamnani L; Burrows N; Telfer BA; Carta F; Winum JY; Scozzafava A; Supuran CT; Williams KJ
J Med Chem; 2012 Jun; 55(11):5591-600. PubMed ID: 22621623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]